Engineered probiotics Clostridium butyricum<scp>‐pMTL007‐GLP</scp>‐1 improves blood pressure via producing <scp>GLP</scp>‐1 and modulating gut microbiota in spontaneous hypertension rat models

MLA

Xin‐liang Wang, et al. “Engineered Probiotics Clostridium Butyricum‐pMTL007‐GLP‐1 Improves Blood Pressure via Producing GLP‐1 and Modulating Gut Microbiota in Spontaneous Hypertension Rat Models.” Microbial Biotechnology, vol. 16, Dec. 2022, pp. 799–812. EBSCOhost, https://doi.org/10.1111/1751-7915.14196.

APA

Xin‐liang Wang, Wen‐jie Chen, Rui Jin, Xuan Xu, Jing Wei, Hong Huang, Yan‐hua Tang, Chang‐wei Zou, & Ting‐tao Chen. (2022). Engineered probiotics Clostridium butyricum‐pMTL007‐GLP‐1 improves blood pressure via producing GLP‐1 and modulating gut microbiota in spontaneous hypertension rat models. Microbial Biotechnology, 16, 799–812. https://doi.org/10.1111/1751-7915.14196

Chicago

Xin‐liang Wang, Wen‐jie Chen, Rui Jin, Xuan Xu, Jing Wei, Hong Huang, Yan‐hua Tang, Chang‐wei Zou, and Ting‐tao Chen. 2022. “Engineered Probiotics Clostridium Butyricum‐pMTL007‐GLP‐1 Improves Blood Pressure via Producing GLP‐1 and Modulating Gut Microbiota in Spontaneous Hypertension Rat Models.” Microbial Biotechnology 16 (December): 799–812. doi:10.1111/1751-7915.14196.